Search Results (63)

Background: The interaction between human immunoglobulin G (IgG)1 Fc and the Fc gamma receptor (FcγR) IIIa/CD16a elicits protective immune responses. Antibody N-glycosylation stabilizes the FcγR-binding interface and is thus essential for interaction with wildtype IgG1 Fc. Furthermore, the N-glycan introduces substantial compositional and functional heterogeneity, with distinct glycoforms providing different affinities and discrete responses in vivo. Accordingly, various engineering endeavors to improve antibody binding strive to boost the therapeutic efficacy of monoclonal antibodies but do not directly address compositional heterogeneity. Objective: Here, we describe a previously unexplored approach to engineer IgG1 Fc. We eliminated carbohydrate heterogeneity by removing the N-glycan but stabilizing the FcγR-binding interface with disulfide bonds. Conclusions: These newly generated Fc domains served as a starting point for protein engineering through yeast surface display to enhance receptor-binding affinity. We recovered Fc variants from this approach that demonstrated FcγRIIIa binding affinities comparable to the starting sequence and thus serve as a proof-of-principle for this strategy. Full article

Two-dimensional (2D) materials have emerged as a key platform for next-generation electronics due to their atomic thickness and tunable properties. Iron disulfide (FeS₂), known as pyrite, with a bandgap of ~0.95 eV, is suitable for solar energy applications. However, its performance is limited by defects in bulk crystals. Reducing FeS₂ to a single layer eliminates bulk defects and enables strain engineering of the bandgap. In this study, First-principles density functional theory (DFT) calculations are performed using the CASTEP code and the PBEsol functional to examine the structural, electronic, and optical properties of a distorted 1T′-phase FeS₂ monolayer. Full geometry optimization yields lattice parameters a′ = 17.594 Å, b′ = 3.20231 Å, c′ = 5.28091 Å, and Fe–S bond angles of ~75.8° and ~98.2°, confirming symmetry-breaking distortion. The monolayer is dynamically stable, showing no imaginary modes in the phonon dispersion, and remains structurally intact up to 1000 K in molecular dynamics simulations. The unstrained system has an indirect bandgap of 0.70 eV, with the valence band maximum at the Γ point (dominated by S-p states) and conduction band minimum near the X point (Fe-d states). Under mechanical strain (±4%), the bandgap decreases significantly: from 0.70 eV to 0.44 eV under +4% tensile strain along the y-axis, and to 0.53 eV under −4% compressive strain. Biaxial strain causes weaker modulation, reducing the gap to 0.66 eV (+4%) and 0.62 eV (−4%). Optical absorption exceeds 10⁴ cm⁻¹ for photon energies above the bandgap, with tensile strain causing redshifts and compressive strain inducing blueshifts. These findings demonstrate that 2D FeS₂ is mechanically robust, electronically tunable, and optically active, making it a promising candidate material for flexible strain sensors and photovoltaic devices. This work is intended to motivate and inform future synthesis efforts. Full article

Adoptive TCR-T cell therapy holds great promise for personalised cancer treatment, yet it is limited by poor surface expression, chain mispairing, and suboptimal stability of introduced TCRs. One effective structure-guided approach is to introduce a second interchain disulfide bond between the α and β constant domains. This review summarises the structural and mechanistic basis of this strategy, its impact on TCR folding, CD3 assembly, mechanotransduction, and anti-tumour function, as well as current engineering approaches, persistent challenges, and future perspectives. Preclinical studies demonstrate improved heterodimer stability, reduced mispairing, higher surface expression, and enhanced signalling, positioning the second disulfide bond as a valuable complementary tool in next-generation TCR engineering. Full article

Thermosets are widely used in engineering applications due to their high mechanical strength, thermal stability, and chemical resistance; however, their permanently crosslinked networks also limit repair, reshaping, and recycling. Dynamic covalent chemistry offers a route to addressing these limitations through the incorporation of reversible bond exchange into thermoset networks. A range of dynamic thermosets has been developed based on transesterification, Diels–Alder reactions, imine exchange, disulfide metathesis, boronic ester exchange, and siloxane equilibration, enabling self-healing, reprocessing, welding, and closed-loop recycling. This review examines representative dynamic thermosets in terms of exchange mechanisms, network topology evolution, and macroscopic response. By correlating molecular exchange processes with network-level mechanics and macroscopic performance, this review identifies design principles for dynamic thermosets with improved sustainability and processing compatibility. Full article

Traditional chemical hair dyes are associated with potential health risks, while botanical alternatives are often hampered by poor stability and limited color longevity. In this study, discarded squid ink was used to prepare bionic hair colorants of high performance. By synergizing ultrasound disruption with enzymatic hydrolysis, the crude ink aggregates were transformed into highly uniform squid ink melanin nanoparticles (SIMNPs) with size and zeta potential of ~174 nm and −37.5 mV, respectively. This effectively improved the solubility but reduced the steric limitation of natural melanin. To overcome the weak affinity between melanin and human hair, a biomimetic interface where Fe(III) ions act as supramolecular bridges was further engineered to stably bind the SIMNPs to hair keratin. Under optimized conditions (pH 8.0, 45 °C, and 80 min), the dyed hair achieved a natural deep black with a total color difference (ΔE*) of 68.79 ± 0.29, which was maintained at 63.19 ± 0.27 even after 13 consecutive water washing cycles. Unlike destructive oxidative dyes, this SIMNP dyeing system assisted by coordination-driven assembly preserved the native α-helical architecture and disulfide bond networks of hair keratin. Furthermore, the deposited SIMNP layer effectively protected hair fibers from ultraviolet (UV) damage due to its powerful UV-shielding capacity. Crucially, in vitro and in vivo evaluations confirmed the exceptional biosafety of this formulation, demonstrating robust cellular tolerance and absence of murine skin irritation. The work demonstrates a green, low-damage paradigm for the development of bio-based hair colorants of high performance and presents a promising pathway for the high-value utilization of marine by-products. Full article

Dynamic covalent bonds are commonly used to maintain the self-healing properties of polyurethanes and facilitate resource recycling. However, relying on a single type of dynamic covalent bond often makes it difficult to effectively regulate both mechanical and self-healing properties across a wide temperature range. In this study, a self-synthesized chain extender containing disulfide bonds was introduced into a polyurethane system, leading to the development of a novel dual-dynamic covalent bond self-healing polyurethane (SSDA-PU). Innovatively, this SSDA-PU demonstrates self-healing properties across a wide temperature range. The successful synthesis of the chain extender and the incorporation of both disulfide bonds and Diels–Alder (DA) bonds were confirmed using FTIR and Raman spectroscopy. The physical characteristics and self-healing performance were comprehensively evaluated through multi-scale testing and characterization, including thermogravimetric analysis (TGA), dynamic mechanical analysis (DMA), hardness testing, mechanical tensile tests, and self-healing experiments. The underlying synergistic self-healing mechanism was subsequently elucidated. Findings showed that a higher R-value (isocyanate index) in SSDA-PU leads to over-crosslinking, while an R-value of 1.7 achieves the best overall mechanical performance, with tensile strength and elongation at break reaching 21.1 MPa and 755.17%, respectively. Additionally, SSDA-PU demonstrated the capacity for multiple healing cycles, with an initial self-healing efficiency of 90.38%, which remained notably high at 59.21% even after three damage-healing cycles. Importantly, SSDA-PU exhibited healing capabilities even at relatively low temperatures. Cracks in SSDA-PU can be effectively repaired through the synergistic action of disulfide bond exchange, hydrogen bond dissociation, and thermally reversible DA reactions. SSDA-PU also shows excellent recyclability, offering valuable insights for the practical engineering application of functional polyurethanes. Full article

Transforming growth factor beta 3 (TGF-β3) is a homodimeric cytokine with potential therapeutic applications in wound healing, tissue engineering and regenerative medicine. Production of recombinant TGF-β3 in Escherichia coli faces significant challenges due to TGF-β3’s propensity for misfolding and aggregation, driven by a high disulfide bond content and low aqueous solubility. To address these limitations, the impacts of substituting non-conserved cysteine residues C7, C16 and C77 with serine on TGF-β3 folding, dimerization and activity were investigated. Whilst C7 and C16 form an intra-chain disulfide bond, C77 forms an inter-chain disulfide bond stabilizing dimer formation. Our results showed that the C7S, C16S double cysteine mutant protein exhibited reduced aggregation, increased dimer formation, and maintained wild-type biological activity in nano-luciferase reporter gene assay. In contrast, both C77S single and C7S, C16S, C77S triple mutants were purified predominantly in monomeric forms and displayed about 2.5-fold reduced activities. Our findings highlight the roles of the non-conserved C7, C16 and C77 cysteine residues in TGF-β3 folding and aggregation. The identification of the C7S, C16S mutant as a more soluble protein with wild-type TGF-β3 activity offers a promising strategy for improving recombinant TGF-β3 production to facilitate therapeutic applications. This study underscores the importance of targeted cysteine engineering to overcome the inherent challenges associated with the production of TGF-β3 and related complex disulfide-rich proteins. Full article

To prepare a modified asphalt with excellent road performance, thermoplastic polyurethane/graphene oxide (TPU/GO) incorporating dynamic disulfide bonds was developed as an additive and the synergistic effect of TPU and GO on asphalt was evaluated. Modified asphalts with different TPU/GO contents (2%, 4%, 6%, 8%) were prepared and TPU-modified asphalts were also prepared as control groups. The compatibility between TPU/GO and asphalt was evaluated by fluorescence microscopy (FM) and the dispersion of GO in TPU and asphalt was observed by emission scanning electron microscope (SEM). The road performance of modified asphalts was also assessed in this study. The FM results show that TPU/GO has good compatibility with asphalt, and the SEM results reveal that GO can be uniformly dispersed in TPU matrix, so that GO can also be evenly dispersed in asphalt and avoid the problem of GO aggregation in asphalt. The results also demonstrate that TPU/GO-modified asphalt comprehensively utilizes the respective advantages of TPU and GO. TPU/GO-modified asphalt has excellent low-temperature performance compared with base asphalt. The 5 °C ductility of 8%TPU/GO-modified asphalt is 440% higher than that of base asphalt and the BBR test also showed that the stress relaxation capacity of TPU/GO-modified asphalt is also significantly stronger than that of base asphalt. Moreover, the introduction of GO in asphalt can improve the creep recovery rate and complex modulus compared with TPU-modified asphalt, indicating better high-temperature rutting resistance. Comprehensive performance evaluation indicates that 8% TPU/GO-modified asphalt is the optimal dosage for engineering applications, balancing high-temperature rutting resistance, storage stability, anti-aging performance, and low-temperature behavior. Full article

Human neuroglobin (Ngb) is a globin featuring a disulfide bond (Cys46–Cys55) and a redox-active cysteine residue (Cys120) and plays a dual role in cellular stress responses. In this study, we investigated how wild-type (WT) Ngb and its two mutants, C120S Ngb, in which Cys120 is replaced by serine, and A15C Ngb, which contains an engineered Cys15–Cys120 disulfide bridge, modulate oxidative stress in triple-negative breast cancer (MDAMB231) and hormone receptor-positive breast cancer (MCF-7) cells. In both cell lines, WT Ngb enhanced cell survival under H₂O₂-induced oxidative stress by scavenging reactive oxygen species (ROS) through oxidation of Cys120. In contrast, the C120S and A15C mutants lost this protective capacity and instead promoted apoptosis. Mass spectrometry analysis confirmed the oxidation of Cys120 to sulfenic acid in WT Ngb, whereas both mutants exhibited impaired redox activity, leading to elevated ROS levels, lipid peroxidation, and activation of caspase-9/3. AO/EB staining further revealed that WT Ngb attenuated DNA damage, while the mutants exacerbated apoptosis in both MDAMB231 and MCF-7 cells. These results demonstrate that Cys120 acts as a critical redox switch, dictating whether Ngb exerts cytoprotective or pro-apoptotic effects across different breast cancer cell types. Our findings suggest that WT Ngb may help protect normal tissues during cancer therapy, whereas engineered Ngb mutants could be used to selectively sensitize both triple-negative and hormone receptor-positive breast cancer cells to oxidative damage, offering a novel redox-targeted therapeutic strategy. Full article

Background: Articular cartilage has limited self-repair capacity. While thermoresponsive poly N-isopropyl acrylamide (pNIPAAm)-based Cell Sheet Engineering (CSE) is a promising scaffold-free strategy, its inherent material properties pose limitations. This study developed and validated a novel, non-thermoresponsive CSE platform for functional cartilage regeneration. Methods: A culture platform was fabricated by grafting the biocompatible polymer poly gamma-glutamic acid (γ-PGA) and a disulfide-containing amino acid onto porous PET membranes. This design enables intact cell sheet detachment with its native extracellular matrix (ECM) via specific cleavage of the disulfide bonds by a mild reducing agent. Results: The hydrated substrate exhibited a biomimetic stiffness (~16.2 MPa) that closely mimics native cartilage. The platform showed superior biocompatibility and supported the cultivation of multi-layered rabbit chondrocyte sheets rich in Collagen II and Glycosaminoglycans. Critically, in a rabbit full-thickness defect model, transplanted autologous cell sheets successfully regenerated integrated, hyaline-like cartilage at 12 weeks, as confirmed by MRI, CT, and histological analyses. Conclusions: This novel CSE platform, featuring highly biomimetic stiffness and a gentle, chemically specific detachment mechanism, represents a highly promising clinical strategy for repairing articular cartilage defects. Full article

Background: Respiratory syncytial virus (RSV) is a major pathogen of acute lower respiratory tract infection (LRTI) in infants, the elderly, and immunocompromised individuals. This review focuses on the progress of RSV vaccine development, especially subunit vaccines targeting the fusion protein (F) and attachment glycoprotein (G), aiming to summarize key strategies, challenges, and future directions in the field. Methods: The review is based on a comprehensive literature search and analysis of recent studies on RSV vaccine development, with a specific focus on subunit vaccines and related technologies. Results: Approved vaccines such as Abrysvo and Arexvy utilize structural engineering to stabilize the prefusion conformation of the F protein (PreF), thereby exposing neutralizing epitopes. Subunit vaccine candidates such as DS-Cav1 and DT-PreF enhance stability through disulfide bonds and dityrosine linkages, while ADV110 targets the conserved domain of the G protein to elicit cross-strain immunity. Virus-like particle (VLP) vaccines like IVX-A12 combine RSV and human metapneumovirus antigens to provide broad-spectrum immunity. However, challenges exist, including maintaining PreF stability, overcoming immunosenescence in the elderly, and addressing safety concerns like Guillain-Barré syndrome (GBS). Conclusions: Future RSV vaccine development should center on combined PreF-G protein vaccines, VLP technology, and optimizing cold-chain logistics to improve global accessibility and overcome existing challenges, thereby providing more effective prevention and control of RSV infections. Full article

Background: Antibodies have revolutionized therapeutics and diagnostics, but their applications are largely restricted to extracellular targets due to challenges in intracellular delivery and stability. Nanobodies, with their small size and lack of disulfide bonds, hold great promise for intracellular use but face challenges such as aggregation and rapid degradation in the cytosol. Methods: To overcome this, we engineered nanobodies by fusing them with subcellular localization motifs to redirect their localization within cells, including the mitochondrial surface, endoplasmic reticulum surface, endomembrane system, and cytoskeleton. Results: Our results demonstrate that nanobodies located in the cytoskeleton or endomembrane exhibit significantly reduced degradation rates and enhanced stability, while maintaining their target-binding capacity. Mechanistically, these modifications lowered ubiquitination levels and prolonged functional activity. Conclusions: This work provides a novel strategy to enhance the intracellular stability and efficacy of nanobodies, expanding their potential applications in functional proteomics, disease research, and therapeutic development. Full article

Non-covalent and dynamic covalent interactions enable supramolecular systems to function as adaptive platforms in biomedical research, offering novel strategies for precision medicine applications. This review examines five-year developments in supramolecular applications across precision medical domains, including disease diagnosis, bioimaging, targeted drug delivery, tissue engineering, and gene therapy. The review begins by systematically categorizing supramolecular structures into dynamic covalent systems (e.g., disulfide bonds, boronate esters, and hydrazone bonds) and dynamic non-covalent systems (e.g., host–guest interactions, hydrogen-bond networks, metal coordination, and π–π stacking), highlighting current strategies employed to optimize their responsiveness, stability, and targeting efficiency. Representative case studies, such as cyclodextrin-based nanocarriers and metal–organic frameworks (MOFs), are thoroughly analyzed to illustrate how supramolecular systems can enhance precision in drug delivery and improve biocompatibility. Furthermore, this article critically discusses major challenges faced during clinical translation, encompassing structural instability, inadequate specificity of environmental responsiveness, pharmacokinetic and toxicity concerns, and difficulties in scalable manufacturing. Potential future directions to overcome these barriers are proposed, emphasizing biomimetic interface engineering and dynamic crosslinking strategies. Collectively, the continued evolution in structural optimization and functional integration within supramolecular systems holds great promise for achieving personalized diagnostic and therapeutic platforms, thereby accelerating their translation into clinical practice and profoundly shaping the future landscape of precision medicine. Full article

Background: Redox-responsive prodrug nanoassemblies (NAs) have been extensively utilized in precise cancer therapy. But there is no research shedding light on the impacts of the π–π stacking interactions on the self-assembly capacity of redox-responsive prodrugs and the in vivo delivery fate of NAs. Methods: Three structurally engineered doxorubicin (DOX) prodrugs (FAD, FBD, and FGD) were developed through α-, β-, and γ-positioned disulfide linkages with π-conjugated Fmoc moieties. The NAs were comprehensively characterized for their self-assembly kinetics, redox-responsive drug release profiles, and physicochemical stability. Biological evaluations included cellular uptake efficiency, in vivo pharmacokinetics, and antitumor efficacy in tumor-bearing mouse models. Results: Systematic characterization revealed that π-conjugated disulfide bond positioning dictates prodrug self-assembly and inversely regulates reductive drug release relative to carbon spacer length. The FBD NAs demonstrated optimal redox-responsive release kinetics while maintaining minimal systemic toxicity, achieving 101.7-fold greater tumor accumulation (AUC) than DiR Sol controls. In 4T1 tumor-bearing models, FBD NAs displayed potent antitumor efficacy, yielding a final mean tumor volume of 518.06 ± 54.76 mm³ that was statistically significantly smaller than all comparator groups (p < 0.001 by ANOVA at a 99% confidence interval). Conclusion: These findings demonstrate that strategic incorporation of redox-sensitive disulfide bonds with different π–π stacking interactions in the prodrug structure effectively optimizes the delivery-release balance of DOX in vivo, ensuring both potent antitumor efficacy and reduced systemic toxicity. Full article

Background: Bispecific antibodies have emerged as a promising class of therapeutics, enabling simultaneous targeting of two distinct antigens. Single-domain antibodies (sdAbs) comprising camelid variable heavy chains (VHHs) provide a compact and adaptable platform for bispecific antibody design due to their small size and ease of linkage. Methods: Here we investigate structure-activity relationship of VHH-based cytokine surrogates by combining cell signaling and functional assays with x-ray crystallography and other biophysical techniques. Results: We describe crystal structures of four unique bispecific VHHs that engage and activate the cytokine receptor pairs IL-18Rα/IL-18Rβ and IL-2Rβ/IL-2Rγ. These bispecific VHH molecules, referred to as surrogate cytokine agonists (SCAs), create unique cytokine signals that can be tuned by linker engineering. Our structural analysis reveals multiple dimeric conformations for these bispecific SCAs, where the two VHH domains can interact to form a compact structure. We demonstrate that the dimeric conformation can be enforced via engineering of a non-native disulfide bond between the VHH subunits, thus enhancing molecular thermostability. Conclusion: Our findings have important implications for the design and engineering of bispecific VHHs or sdAbs, offering a novel strategy for tuning their activity and increasing their stability. Full article